Keros Therapeutics, Inc. (KROS)
NASDAQ·Healthcare·Biotechnology
$10.19
+1.39%
Mkt Cap $329.58M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
Implied Upside
+906.9%
Consensus $102.60 vs current $10.19
NASDAQ·Healthcare·Biotechnology
$10.19
+1.39%
Mkt Cap $329.58M
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
+906.9%
Consensus $102.60 vs current $10.19